CALGARY, AB, April 23, 2024 /CNW/ - CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), – Canadabis Capital, and its shareholdings in Stigma Grow a leading innovator in the Canadian cannabis industry, is thrilled to announce the launch of the latest addition to the Dab Bods brand lineup – a ground breaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market, catering to cannabis enthusiasts seeking a premium, high-potency experience.

"We are incredibly excited to introduce this revolutionary product to our customers," said Travis Mcintyre, CEO of Canadabis Capital. "The 60%+ double-infused pre-roll represents our commitment to innovation and quality, and we believe it will set a new standard for excellence in the Canadian cannabis market."

The Dab Bods brand is known for its exceptional quality and premium cannabis products. The new 60%+ double-infused pre-roll is no exception, offering consumers a unique and potent experience unlike any other product on the market. Dab Bods continues to bring new innovations to the Canadian market. The new 60%+ double-infused pre-roll from the Dab Bods brand is now available for purchase in Alberta at select retailers and soon to be available across Canada.

ABOUT CANADABIS CAPITAL INC.

CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth, from cultivation to retail, in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.

Our integrated subsidiaries:

• Stigma Pharmaceuticals Inc. – 100% held

• 1998643 Alberta Ltd. (operating as "Stigma Grow") - 100% held; www.stigmagrow.ca

• Full Spectrum Labs Ltd. (operating as "Stigma Roots") - 100% held

• 2103157 Alberta Ltd. -100% held

• Goldstream Cannabis Inc. - 95% held

ABOUT STIGMA GROW

Stigma Grow is a cutting-edge cannabis cultivation and extraction company positioned advantageously to meet the unmet market demands and stigmas within the legal cannabis industry head on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada's legal cannabis industry.

CAUTIONARY STATEMENTS

Regarding Forward-Looking Information

This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include but are not limited to statements with respect to our business and operations; the focus of our 2024 activities, our continued cost saving initiatives, our outlook and the plan to seek further growth initiatives. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company's products to compete with the pricing and product availability; the market demand for the Company's products; and assumptions concerning the Company's competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create a demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company's continuous disclosure on SEDAR at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.